Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

DZIF Prize for Translational Research: Prof Dirk Heinz (left) presents the award, worth 5000 euros, to Prof Markus Gerhard, TUM.
© DZIF

Markus Gerhard receives the DZIF Prize for Translational Infection Research

His aim is to develop a vaccine against the widespread gastric pathogen Helicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the

Capsule containing frozen gut flora for treating diarrhoeal diseases.
© DZIF

Gut flora transfer: How does healthy gut flora get into a capsule?

DZIF scientists at the University Hospital Cologne produce frozen gut flora preparations in capsules. The production protocol is freely accessible for interested colleagues.

Clostridium difficile inf

Joint DGI and DZIF Annual Meeting in Munich

Infectious diseases are a leading cause of death worldwide. Current problems such as antibiotic resistance, declining vaccination rates and emerging infections like Ebola present scientists and

Ghanaian leaf-nosed bat: Bats form reservoirs for various viruses.als Reservoir.
© Marco Tschapka/Uni Ulm

The hepatitis A virus is of animal origin

The hepatitis A virus – like HIV or Ebola as well – is of likely animal origin. An international team of researchers under the lead of the University of Bonn uncovered the evolutionary origins of the

Drug design: Making sugar molecules aggressive

Breaking down bacterial biofilms in order to lure the pathogens out of hiding is one of chemist Dr Alexander Titz’s goals. The junior research group leader from the Helmholtz Institute for

MERS Corona virus particles outside the cell
© NIAID

MERS coronavirus: Vaccine candidate reveals efficacy in mouse model

Researchers of the Paul Ehrlich Institute (PEI) together with groups at the DZIF have developed a vaccine against MERS, that is highly immunogenic and indicates protection of vaccinated mice in

Plaque test
© Udo Thomas/GARP

Cyanobacteria protect against oral herpes

DZIF scientists at the Heinrich Pette Institute in Hamburg have shown that a cream containing Spirulina platensis, a cyanobacterium, effectively protects against oral herpes and other herpes virus

N/A
© HPI, Foto: Udo Thomas/GARP

New treatment approach found for hepatitis B

DZIF scientists from the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology have identified two sequences in the hepatitis B virus (HBV) genome that could be targeted for

Stuhltransplantation MHH
© MHH/Kaiser

Unusual therapy for gut flora

Doctors at the Hannover Medical School (MHH) have succeeded in curing a patient suffering from a life-threatening diarrhoeal disease with an unusual treatment method: They transplanted a healthy

Scanning electron microscope image of HIV-1 on lymphocytes
© cdc/C. Goldsmith

HIV Therapy: The earlier, the better

Patients infected with HIV have several benefits if they are treated with antiviral medication earlier than has been usual up to now: for a start, the severe AIDS-related complications occur less